Skip to content

Elucidation of the mechanism of action of low-frequency therapy.

Elucidation of the mechanism of action of low-frequency therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1012230046
Enrollment
50
Registered
2023-11-11
Start date
2023-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy human

Interventions

Perform stimulation with a low-frequency therapy device. During stimulation, avoid splashing water on the body and electrodes, and allow walking and moving around, but only to the extent that the elec

Sponsors

Satoshi Konnno
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (i) Persons aged 18 years or over at the time of obtaining consent. (ii) Persons who do not have rheumatoid arthritis, spondyloarthritis, osteoarthritis or interstitial pneumonia (iii) Persons who understand the purpose of the study and have given their free and voluntary written consent to participate.

Exclusion criteria

Exclusion criteria: (i) Those who have developed acute heart failure, myocardial infarction, pulmonary oedema or acute exacerbation of interstitial pneumonia within the past 3 months. (ii) Those with a history of cerebral or central nervous system lesions (iii) Those receiving concomitant vagus nerve stimulation therapy (iv) Those with a history of epilepsy (v) Those with a history of severe cardiovascular disease (vi) Persons with pneumothorax (vii) Persons with uncontrolled infections (viii) Pregnant or lactating women (ix) Persons with skin hypersensitivity and a history of skin symptoms caused by metal or other substances. (x) Persons with difficulty in oral intake. (xi) Those with severe renal dysfunction (estimated glomerular filtration rate (eGFR) < 30 ml/min). (xiii) Persons with a cardiac pacemaker or implantable cardioverter-defibrillator. Persons who are ineligible to participate in the study on the attached 'MRI Questionnaire'. (iv) Other subjects who are deemed inappropriate as research subjects by the Principal Investigator or the Research Assigning Physician.

Design outcomes

Primary

MeasureTime frame
Comparison of the degree of T cell activation by anti-CD3/CD28 antibodies before and after stimulation.

Secondary

MeasureTime frame
1. comparison with previous reports in patients with diseases related to the activation state of immune cells (rheumatoid arthritis, inflammatory bowel syndrome, knee osteoarthritis, interstitial pneumonia, epilepsy) 2. comparison with samples from patients with diseases regarding the expression positivity and intensity of a group of molecules whose expression is induced by low-frequency stimulation 3. comparison with previous reports on disease-related gene variants in patients with disease 4. correlation between brain activity data in MRI and expression of various analysed molecules

Contacts

Public ContactKojima Yuichi

Hokkaido University Hospital

yu1.kojima@pop.med.hokudai.ac.jp+81-11-706-5911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026